Quick fix for drug allergies: new study aims to keep PKU patients on treatment
NCT ID NCT06780332
First seen Apr 10, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tests a one-day rapid drug desensitization (RDD) procedure in 9 adults with phenylketonuria (PKU) who have had allergic reactions to their medication Palynziq. The goal is to see if RDD allows them to restart and stay on Palynziq without severe allergic reactions, helping them manage their condition more effectively. Participants will be followed for 24 weeks after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Uncommon Cures
Chevy Chase, Maryland, 20815, United States
Conditions
Explore the condition pages connected to this study.